Free T4 index and clinical outcome in patients with depression

Journal of Affective Disorders

Volumn 100, Issue 1-3, 2007, Pages 271-277

  Abulseoud, Osama ^a   Sane, Natasha ^a   Cozzolino, Anthony ^a   Kiriakos, Lindsay ^a   Mehra, Vishal ^a   Gitlin, Michael ^a   Masseling, Susan ^a   Whybrow, Peter ^a   Altshuler, Lori L ^a   Mintz, Jim ^a   Frye, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Depression; Gender; Thyroid function; Treatment response

Indexed keywords

AMFEBUTAMONE; BENZODIAZEPINE; CARBAMAZEPINE; IMIPRAMINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THYROXINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM; VENLAFAXINE; ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BIPOLAR DEPRESSION; DEPRESSION; FEMALE; FREE THYROXINE INDEX; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; THYROID FUNCTION; TREATMENT RESPONSE; BLOOD; THYROID FUNCTION TEST; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSION; FEMALE; HUMANS; MALE; SEX FACTORS; THYROID FUNCTION TESTS; THYROXINE; TREATMENT OUTCOME;

EID: 34249286563     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.10.012     Document Type: Article

References (57)

1. Allison P.D. Survival Analysis Using the SAS System: A Practical Guide (1995), SAS Institute, Cary N.C
2. Altshuler L.L., Bauer M., Frye M.A., et al. Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Am. J. Psychiatry 158 (2001) 1617-1622
3. Amsterdam J.D., Fava M., Maislin G., et al. TRH stimulation test as a predictor of acute and long-term antidepressant response in major depression. J. Affect Disord. 5 38(2-3) (1996) 165-172
4. Banki C.M., Bissette G., Arato M., et al. Elevation of immunoreactive CSF TRH in depressed patients. Am. J. Psychiatry 145 (1988) 1526-1531
5. Bauer M.S., and Whybrow P.C. Thyroid hormones and the central nervous system in affective illness: interactions that may have clinical significance. Integr. Psychiatr. 6 (1988) 75
6. Bauer M.S., and Whybrow P.C. Rapid cycling bipolar affective disorder: II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch. Gen. Psychiatry 47 5 (1990) 435-440
7. Baumgartner A., Graf K.J., Kurten I., and Meinhold H. The hypothalamic-pituitary-thyroid axis in psychiatric patients and healthy subjects: Parts 1-4. Psychiatry Res. 24 3 (1988) 271-332
8. Baumgartner A., Bauer M., and Hellweg R. Treatment of intractable non-rapid cycling bipolar affective disorder with high-dose thyroxine: an open clinical trial. Neuropsychopharmacology 10 3 (1994) 183-189
9. Brady K.T., and Anton R.F. The thyroid axis and desipramine treatment in depression. Biol. Psychiatry 25 6 (1989) 703-709
10. Braunwald E. Harrison's Principles of Internal Medicine. 11th edition (1987), McGraw-Hill Book Company 1736
11. Cole D.P., Thase M.E., Mallinger A.G., et al. Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function. Am. J. Psychiatry 159 (2002) 116-121
12. Coppen A., Whybrow P.C., Noguera R., et al. The comparative antidepressant value of l-tryptophan and imipramine with and without attempted potentiation by liothyronine. Arch. Gen. Psychiatry 26 (1972) 234-241
13. Duval F., Macher J., and Mokrani M. Differences between evening and morning thyrotropin responses to protirelin in major depressive episode. Arch. Gen. Psychiatry 47 (1990) 443-448
14. Duval F., Mokrani M., Crocq M., et al. Influence of thyroid hormones on morning and evening TSH response to TRH in major depression. Biol. Psychiatry 35 (1994) 926-934
15. Duval F., Mokrani M., Bailey P., et al. Thyroid axis activity and serotonin function in major depressive episode. Psychoneuroendocrinology 24 (1999) 695-712
16. Fava M., Labbate L., Abraham M., et al. Hypothyroidism and hyperthyroidism in major depression revisited. J. Clin. Psychiatry 56 5 (1995) 186-192
17. Feighner J., King L., Schuckit M., et al. Hormonal potentiation of imipramine and ECT in primary depression. Am. J. Psychiatry 128 10 (1972) 1230-1238
18. Frye M.A., Gary K.A., Little J.T., et al. CSF TRH gender difference: implications for neurobiological study and treatment of depression. J. Neuropsychiatry Clin. Neurosci. 11 (1999) 349-353
19. Gendall K., Joyce P., Mulder R., et al. Thyroid indices and response to fluoxetine and nortriptyline in major depression. J. Psychopharmacol. 17 4 (2003) 431-437
20. Gold P.W., Goodwin F.K., Wehr T., et al. Pituitary thyrotropin response to thyrotropin-releasing hormone in affective illness: relationship to spinal fluid amine metabolites. Am. J. Psychiatry 134 9 (1977) 1028-1031
21. Hatterer J., Herbert J., Hidaka C., et al. CSF transthyretin in patients with depression. Am. J. Psychiatry 150 5 (1993) 813-815
22. Hurowitz G.I., and Liebowitz M.R. Antidepressant-induced rapid cycling: six case reports. J. Clin. Psychopharmacol. 13 1 (1993) 52-56
23. Joffe R.T., and Singer W. Effect of phenelzine on thyroid function in depressed patients. Biol. Psychiatry. 22 8 (1987) 1033-1035
24. Joffe R.T., and Singer W. The effect of tricyclic antidepressants on basal thyroid hormone levels in depressed patients. Pharmacopsychiatry 23 (1990) 67-69
25. Joffe R.T., and Singer W. Antidepressants and thyroid hormone levels. Acta Med. Austriaca 19 Suppl. 1 (1992) 96-97
26. Joffe R.T., and Sokolov S.T. Thyroid hormones, the brain, and affective disorders. Crit. Rev. Neurobiol. 8 1/2 (1994) 45-63
27. Joffe R.T., Singer W., and Levitt A.J. Methimazole in treatment-resistant depression. Biol. Psychiatry 31 (1992) 1235-1237
28. Joffe R.T., Segal Z., and Singer W. Change in thyroid hormone levels following response to cognitive therapy for major depression. Am. J. Psychiatry 153 (1996) 411-413
29. Kessler R.C., McGonagle K.A., Zhao S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch. Gen. Psychiatry 51 1 (1994) 8-19
30. Kirkegaard C., and Faber J. Altered serum levels of thyroxine, triiodothyronines and diiodothyronines in endogenous depression. Acta Endocrinol. 96 (1981) 199-207
31. Kirkegaard C., and Faber J. Influence of free thyroid hormone levels on the TSH response to TRH in endogenous depression. Psychoneuroendocrinology 11 4 (1986) 491-497
32. Kirkegaard C., and Faber J. Free thyroxine and 3,3′,5′-triiodothyronine levels in cerebrospinal fluid in patients with endogenous depression. Acta Endocrinol. 124 (1991) 166-172
33. Kirkegaard C., Faber J., Hummer L., and Rogowski P. Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression. Psychoneuroendocrinology 4 3 (1979) 227-235
34. Kirkegaard C., Kørner A., and Faber. Increased production of thyroxine and inappropriately elevated serum thyrotropin levels in endogenous depression. Biol. Psychiatry 27 (1990) 472-476
35. Kornstein S.G., Schatzberg A.F., Thase M.E., et al. Gender difference in treatment response to sertraline vs. imipramine in chronic depression. Am. J. Psychiatry 157 (2000) 1445-1452
36. Langer G., Koinig G., Hatzinger R., et al. Response of thyrotrop thyrotropin-releasing hormone as predictor of treatment outcome. Arch. Gen. Psychiatry 46 (1986) 861-868
37. Larsen T.R. Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones. N. Engl. J. Med. 306 (1982) 23-32
38. Leibow D. l-Thyroxine for rapid-cycling bipolar illness. Am. J. Psychiatry 140 9 (1983) 1255
39. Linnoila M., Lamberg B.A., Rosberg G., et al. Thyroid hormones and TSH, prolactin and LH responses to repeated TRH and LRH injections in depressed patients. Acta Psychiatr. Scand. 59 5 (1979) 536-544
40. MacQueen G.M., and Joffe R.T. A review of gender differences in studies of thyroid function and major depression. Psychiatr. Ann. 32 8 (2002) 477-482
41. Maes M., Meltzer H.Y., Cosyns P., et al. An evaluation of basal hypothalamic-pituitary-thyroid axis function in depression: results of a large-scaled and controlled study. Psychoneuroendocrinology 18 8 (1993) 607-620
42. Marangell L.B., George M.S., Callahan A.M., et al. Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients. Arch. Gen. Psychiatry 54 3 (1997) 214-222
43. Müller B., and Böning J. Changes in the pituitary-thyroid axis accompanying major affective disorders. Acta Psychiatr. Scand. 77 (1988) 143-150
44. Prange Jr. A.J., Wilson I.C., Rabon A.M., et al. Enhancement of imipramine antidepressant activity by thyroid hormone. Am. J. Psychiatry 126 4 (1969) 457-469
45. Rao M.L., Ruhrmann R.S., Retey B., et al. Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome. Pharmacopsychiatry 29 (1996) 180-186
46. Roy-Byrne P.P., Joffe R.T., Uhde T.W., and Post R.M. Carbamazepine and thyroid function in affectively ill patients: clinical and theoretical implications. Arch. Gen. Psychiatry 41 (1984) 1150-1153
47. Rudas S., Schmitz M., Pichler P., and Baumgartner A. Treatment of refractory chronic depression and dysthymia with high-dose thyroxine. Biol. Psychiatry 45 2 (1999) 229-233
48. Sokolov S.T., Kutcher S.P., and Joffe R.T. Changes in thyroid hormone levels associated with desipramine response in adolescent depression. Prog. Neuro-psychopharmacol. Biol. Psychiatry 20 6 (1996) 1053-1063
49. 3 augmentation. Psychiatry Res. 69 (1997) 203-206
50. Stancer, and Persad. Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine. Clin. Observations Arch. Gen. Psychiatry 39 3 (1982) 311-312
51. Sullivan G., Hatterer J.A., Herbert J., et al. Low levels of transthyretin in the CSF of depressed patients. Am. J. Psychiatry 156 (1999) 710-715
52. Sullivan G.M., Mann J.J., Oquendo M.A., et al. Low cerebrospinal fluid transthyretin levels in depression: correlations with suicidal ideation and low serotonin function. Biol Psychiatry 60 5 (2006) 500-506
53. Wahby V.S., Ibrahim G.A., Giller E.L., et al. Relationship of age to TSH response to TRH in depressed men. Acta Psychiatr. Scand. 78 (1988) 283-288
54. Wheatley D. Potentiation of amitriptyline by thyroid hormone. Arch. Gen. Psychiatry 26 3 (1972) 229-233
55. Whybrow P.C., Coppen A., Prange A.J., et al. Thyroid function and the response to liothyronine in depression. Arch. Gen. Psychiatry 26 (1972) 242-245
56. Wilson I.C., Prange A.J., McClane T.K., et al. Thyroid-hormone enhancement of imipramine in nonretarded depressions. N. Engl. J. Med. 282 (1970) 1063-1067
57. Wilson I.C., Prange Jr. A.J., and Lara P.P. l-Triiodothyronine alone and with imipramine in the treatment of depressed women. In: Prange Jr. A.J. (Ed). The Thyroid Axis, Drugs, and Behavior (1974), Raven Press, New York 49-62